0001950047-24-000428.txt : 20240123 0001950047-24-000428.hdr.sgml : 20240123 20240123161958 ACCESSION NUMBER: 0001950047-24-000428 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 24552896 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Albers Jeffrey W. CENTRAL INDEX KEY: 0001638474 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORP. STREET 2: 215 FIRST STREET, SUITE 340/350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001638474 XXXXXXXX LIVE 0001815442 KYMERA THERAPEUTICS INC 001-39460 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 8572855300 JEFFREY ALBERS Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

10000 292900.00 55487373 01/23/2024 NASDAQ Common 01/23/2024 Exercise of Stock Options Issuer N 10000 01/23/2024 Cash Y 01/23/2024 06/22/2023 /s/ Jeffrey W Albers